Compare TATT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TATT | CYRX |
|---|---|---|
| Founded | 1985 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.2M | 472.7M |
| IPO Year | 1987 | N/A |
| Metric | TATT | CYRX |
|---|---|---|
| Price | $53.41 | $11.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $48.40 | $12.83 |
| AVG Volume (30 Days) | 188.1K | ★ 351.6K |
| Earning Date | 11-12-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.30 | N/A |
| EPS | ★ 1.33 | 1.27 |
| Revenue | $172,525,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $17.20 | $9.27 |
| P/E Ratio | $39.41 | ★ $8.49 |
| Revenue Growth | 20.72 | ★ 41.27 |
| 52 Week Low | $23.37 | $4.58 |
| 52 Week High | $53.74 | $11.44 |
| Indicator | TATT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 74.69 | 65.26 |
| Support Level | $50.75 | $10.39 |
| Resistance Level | $52.83 | $11.38 |
| Average True Range (ATR) | 2.14 | 0.47 |
| MACD | 0.13 | 0.07 |
| Stochastic Oscillator | 95.97 | 81.44 |
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.